Please log in to view this page
Username
Password
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
